State AL
Clinical Trials in Alabama
Alabama is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Alabama and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 190 actively recruiting studies with Alabama sites out of 190 registered in total. The busiest research areas in Alabama are B Acute Lymphoblastic Leukemia, Atopic Dermatitis, Multiple Sclerosis. Leading sponsors running trials in the state include University of Alabama at Birmingham, National Cancer Institute (NCI), Novartis Pharmaceuticals. By stage, Alabama trials break down as Phase 1 (26), Phase 2 (54), Phase 3 (47), Phase 4 (5).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Alabama
Frequently Asked Questions — Clinical Trials in Alabama
How many clinical trials are currently recruiting in Alabama?
ClinicalMetric currently tracks 190 actively recruiting clinical trials with at least one location in Alabama. The total number of registered studies—including active but not currently enrolling trials—is 190. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Alabama?
Alabama hosts clinical trials across a broad range of medical conditions, including B Acute Lymphoblastic Leukemia, Atopic Dermatitis, Multiple Sclerosis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alabama serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Alabama?
To join a clinical trial in Alabama, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alabama maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Alabama
NCT04294043 Phase 1
Recruiting
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
Condition
Nontuberculous Mycobacterium Infection
Enrollment
40 pts
Location
United States
Sponsor
Chris Goss
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
NCT05640102 N/A
Recruiting
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Partic...
Condition
Waldenstrom Macroglobulinemia
Enrollment
111 pts
Location
United States, Puerto Rico
Sponsor
BeiGene
NCT07230288 Phase 2
Recruiting
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adu...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
165 pts
Location
United States, Australia, Bulgaria
Sponsor
AbbVie
NCT07080242 Phase 1
Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell L...
Condition
Small Cell Lung Cancer Metastatic or Locally Advanced
Enrollment
120 pts
Location
United States
Sponsor
SystImmune Inc.
NCT05776056 Phase 4
Recruiting
Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complai...
Condition
Posttraumatic Stress Disorder (PTSD)
Enrollment
70 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05952453 Phase 2
Recruiting
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Mai...
Condition
Ovarian Cancer
Enrollment
20 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT07569029 Phase 1
Recruiting
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA ...
Condition
HIV
Enrollment
42 pts
Location
United States, Argentina, Peru
Sponsor
National Institute of Allergy
NCT07284667 Phase 2
Recruiting
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant...
Condition
Major Depressive Disorder (MDD)
Enrollment
153 pts
Location
United States
Sponsor
ACADIA Pharmaceuticals Inc.
NCT07626411 Phase 3
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibril...
Condition
Atrial Fibrillation (AF)
Enrollment
15,364 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT06124157 Phase 2
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatme...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
222 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT03538665 N/A
Recruiting
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovaria...
Condition
Endometrial Cancer
Enrollment
1,700 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06872892 Phase 3
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With B...
Condition
Bronchiectasis
Enrollment
1,755 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT04042844 Phase 2
Recruiting
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Condition
Lumbar Disc Disease
Enrollment
99 pts
Location
United States
Sponsor
BioRestorative Therapies
NCT05511363 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis As...
Condition
Psychosis Associated With Alzheimer's Disease
Enrollment
410 pts
Location
United States, Bulgaria, Croatia
Sponsor
Karuna Therapeutics, Inc., a B
Page 8 of 8 — 190 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology